These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 35954176)

  • 41. Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.
    Gandhi NS; Tekade RK; Chougule MB
    J Control Release; 2014 Nov; 194():238-56. PubMed ID: 25204288
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Appraisal for the Potential of Viral and Nonviral Vectors in Gene Therapy: A Review.
    Butt MH; Zaman M; Ahmad A; Khan R; Mallhi TH; Hasan MM; Khan YH; Hafeez S; Massoud EES; Rahman MH; Cavalu S
    Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 36011281
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nanotechnology, in silico and endocrine-based strategy for delivering paclitaxel and miRNA: Prospects for the therapeutic management of breast cancer.
    Ansari MA; Thiruvengadam M; Farooqui Z; Rajakumar G; Sajid Jamal QM; Alzohairy MA; Almatroudi A; Alomary MN; Chung IM; Al-Suhaimi EA
    Semin Cancer Biol; 2021 Feb; 69():109-128. PubMed ID: 31891780
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Therapeutic prospects of microRNAs in cancer treatment through nanotechnology.
    Awasthi R; Rathbone MJ; Hansbro PM; Bebawy M; Dua K
    Drug Deliv Transl Res; 2018 Feb; 8(1):97-110. PubMed ID: 29185148
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bioinspired peptides as versatile nucleic acid delivery platforms.
    Gopal V
    J Control Release; 2013 May; 167(3):323-32. PubMed ID: 23474032
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Development of Novel Drug Delivery System Targeting Exosomal microRNA].
    Yamayoshi A
    Yakugaku Zasshi; 2020; 140(5):625-631. PubMed ID: 32378662
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The linkage between microRNA and cancer and its delivery as cancer therapy: A mini-review.
    Syed Najmuddin SUF; Kamarudin AA; Abdul Sani S; Norrrahim MNF; Abdul Latif N'; Wah LGP
    Cell Mol Biol (Noisy-le-grand); 2023 Jul; 69(7):7-18. PubMed ID: 37715444
    [TBL] [Abstract][Full Text] [Related]  

  • 48. miRacle of microRNA-Driven Cancer Nanotherapeutics.
    Kara G; Arun B; Calin GA; Ozpolat B
    Cancers (Basel); 2022 Aug; 14(15):. PubMed ID: 35954481
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The therapeutic potential of microRNAs in cancer.
    Thorsen SB; Obad S; Jensen NF; Stenvang J; Kauppinen S
    Cancer J; 2012; 18(3):275-84. PubMed ID: 22647365
    [TBL] [Abstract][Full Text] [Related]  

  • 50. miRNA therapeutics: delivery and biological activity of peptide nucleic acids targeting miRNAs.
    Fabbri E; Brognara E; Borgatti M; Lampronti I; Finotti A; Bianchi N; Sforza S; Tedeschi T; Manicardi A; Marchelli R; Corradini R; Gambari R
    Epigenomics; 2011 Dec; 3(6):733-45. PubMed ID: 22126292
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nanotechnology based approaches for detection and delivery of microRNA in healthcare and crop protection.
    Chaudhary V; Jangra S; Yadav NR
    J Nanobiotechnology; 2018 Apr; 16(1):40. PubMed ID: 29653577
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aptamer-MiRNA Conjugates for Cancer Cell-Targeted Delivery.
    Esposito CL; Catuogno S; de Franciscis V
    Methods Mol Biol; 2016; 1364():197-208. PubMed ID: 26472452
    [TBL] [Abstract][Full Text] [Related]  

  • 53. miRNA cassettes in viral vectors: problems and solutions.
    Liu YP; Berkhout B
    Biochim Biophys Acta; 2011; 1809(11-12):732-45. PubMed ID: 21679781
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Therapeutic microRNA Delivery Strategies with Special Emphasis on Cancer Therapy and Tumorigenesis: Current Trends and Future Challenges.
    Chakraborty C; Wen ZH; Agoramoorthy G; Lin CS
    Curr Drug Metab; 2016; 17(5):469-77. PubMed ID: 26813887
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MicroRNA dysregulation in cancer: opportunities for the development of microRNA-based drugs.
    Nana-Sinkam SP; Croce CM
    IDrugs; 2010 Dec; 13(12):843-6. PubMed ID: 21154140
    [TBL] [Abstract][Full Text] [Related]  

  • 56. miRNAs in gastrointestinal diseases: can we effectively deliver RNA-based therapeutics orally?
    Hossian AKMN; Mackenzie GG; Mattheolabakis G
    Nanomedicine (Lond); 2019 Nov; 14(21):2873-2889. PubMed ID: 31735124
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cell-penetrating peptides for the delivery of nucleic acids.
    Lehto T; Kurrikoff K; Langel Ü
    Expert Opin Drug Deliv; 2012 Jul; 9(7):823-36. PubMed ID: 22594635
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-based therapeutics for cancer.
    Wang V; Wu W
    BioDrugs; 2009; 23(1):15-23. PubMed ID: 19344188
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improving miRNA Delivery by Optimizing miRNA Expression Cassettes in Diverse Virus Vectors.
    Herrera-Carrillo E; Liu YP; Berkhout B
    Hum Gene Ther Methods; 2017 Aug; 28(4):177-190. PubMed ID: 28712309
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Progress in systemic co-delivery of microRNAs and chemotherapeutics for cancer treatment by using lipid-based nanoparticles.
    He W; Turkeshi A; Li X; Zhang H
    Ther Deliv; 2020 Sep; 11(9):591-603. PubMed ID: 32933403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.